| 產(chǎn)品名稱 |
Lactobacillus iners |
| 商品貨號(hào) |
B191607 |
| Deposited As |
Unidentified coryneform |
| Strain Designations |
AB107 |
| Application |
Produces FcrV protein protein V Produces protein V, which binds with all four subclasses of human IgG |
| Isolation |
Patient with bacterial vaginosis |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Storage Conditions |
Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol® |
no |
| Type Strain |
no |
| Comments |
Formerly known as Gardnerella vaginalis. However, 16S sequencing indentifies this organism as Lactobacillus iners. |
| Medium |
ATCC® Medium 1685: NYC III medium
ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
|
| Growth Conditions |
Temperature: 37°C
Atmosphere: 5% CO2 |
| Name of Depositor |
North Carolina A&T State University |
| U.S. Patent Number |
|
| References |
Allen JW. Protein V:A IGG binding factor. US Patent 5,128,451 dated Jul 7 1992
|
